HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hemant Menghani Selected Research

Hemant Menghani Research Topics

Disease

2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2020 - 01/2017
2Infarction (Infarctions)
11/2020 - 01/2017
2Stroke (Strokes)
11/2020 - 08/2018
2Ischemic Stroke
08/2018 - 01/2017
1Glioblastoma (Glioblastoma Multiforme)
01/2021
1Inflammation (Inflammations)
01/2021
1Neoplasms (Cancer)
01/2021
1Ischemia
01/2017

Drug/Important Bio-Agent (IBA)

2Docosahexaenoic AcidsIBA
11/2020 - 08/2018
1LipidsIBA
01/2021
1LAU 0901IBA
01/2021
1Bevacizumab (Avastin)FDA Link
01/2021
1KetamineFDA LinkGeneric
01/2021
1LuciferasesIBA
01/2021
1Xylazine (Xylazin)IBA
01/2021
1Cell Surface ReceptorsIBA
11/2020
1Proteins (Proteins, Gene)FDA Link
11/2020
1protectin D1IBA
08/2018
1Bromodeoxyuridine (BrdU)IBA
08/2018
1SodiumIBA
01/2017
1EstersIBA
01/2017
1Glucose (Dextrose)FDA LinkGeneric
01/2017
1Oxygen (Dioxygen)IBA
01/2017
1SaltsIBA
01/2017
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2017

Therapy/Procedure

1Therapeutics
01/2021